PPARD and hydrops fetalis: Besides, the treatment with the PPAR-β/δ agonist led to higher PPAR-β/δ gene expression in C-β (+215%, P<0.0001, Fig 5B) and in HF-β (+4369%, P<0.0001, Fig 5B) than in its counterparts.